Can co-trimoxazole (trimethoprim‑sulfamethoxazole) cause facial hyperpigmentation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Co-trimoxazole Does Not Cause Blackish Facial Discoloration

Co-trimoxazole (trimethoprim-sulfamethoxazole) is not associated with blackish facial discoloration or hyperpigmentation. The documented cutaneous adverse effects of this medication are distinctly different from pigmentary changes.

Known Cutaneous Adverse Effects of Co-trimoxazole

The dermatologic reactions associated with co-trimoxazole are well-characterized in multiple guidelines and include:

Common Skin Reactions

  • Maculopapular rash (most frequent cutaneous manifestation)
  • Urticarial eruptions
  • Photosensitivity reactions 1
  • Pruritus

Severe but Rare Reactions

  • Stevens-Johnson syndrome
  • Toxic epidermal necrolysis
  • Erythema multiforme
  • Exfoliative dermatitis 1

These reactions occur in approximately 16% of children and up to 40-65% of HIV-infected adults, with the majority being mild cutaneous eruptions 2.

Fixed Drug Eruption: The Only Pigmentary Change

The only documented pigmentary change associated with co-trimoxazole components is fixed drug eruption from trimethoprim 3. However, this presents as:

  • Circular erythematous lesions that become violaceous
  • Post-inflammatory hyperpigmentation in the same localized areas with each drug exposure
  • Not generalized facial hyperpigmentation
  • Not blackish discoloration

Important Distinction: Minocycline vs. Co-trimoxazole

If you are seeing blackish facial discoloration, consider minocycline instead. Minocycline (a tetracycline antibiotic) is specifically associated with pigment deposition of the skin, mucous membranes, and teeth, particularly with higher doses and longer treatment duration 1. This is a well-documented adverse effect that does not occur with co-trimoxazole.

Clinical Pitfalls to Avoid

  • Do not confuse the photosensitivity reactions of co-trimoxazole (which can cause acute sunburn-like reactions) with chronic pigmentary changes
  • Do not attribute generalized facial hyperpigmentation to co-trimoxazole without considering alternative causes
  • Consider other medications the patient may be taking, particularly minocycline or other tetracyclines
  • Evaluate for post-inflammatory hyperpigmentation from resolved drug eruptions rather than active drug-induced pigmentation

Bottom Line

Co-trimoxazole causes various cutaneous hypersensitivity reactions but not blackish facial discoloration. If facial hyperpigmentation is present, investigate alternative causes including other medications (especially minocycline), underlying dermatologic conditions, or post-inflammatory changes from previous drug reactions 1.

References

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2016

Research

Trimethoprim associated fixed drug eruption.

The British journal of dermatology, 1987

Related Questions

Is Bactrim (trimethoprim/sulfamethoxazole) effective against Staphylococcus epidermidis?
For an otherwise healthy adult with an acute fingertip abscess (felon), how many days should trimethoprim‑sulfamethoxazole (Bactrim) be prescribed?
Can I use trimethoprim‑sulfamethoxazole for a foot ulcer?
Can I use sulfamethoxazole‑trimethoprim (SMX‑TMP) for a skin infection?
Is it safe to give a bed‑bound patient two double‑strength tablets of Bactrim (trimethoprim‑sulfamethoxazole) for a bilateral toe MRSA skin infection?
Are the palmar and plantar rashes associated with secondary syphilis and rickettsial infections painful?
What pharmacokinetic failure could explain the lack of response in a patient receiving olanzapine 20 mg daily and zuclopenthixol decanoate 200 mg weekly who remains manic with psychotic features and requires multiple PRN (as‑needed) medications?
What is the recommended treatment for hepatorenal syndrome in a patient with liver cancer?
What are the possible causes for a woman with recurrent cutaneous eruptions, asthma, an idiosyncratic reaction to non‑steroidal anti‑inflammatory drugs (NSAIDs), marked peripheral eosinophilia, and unexplained hyperkalaemia despite normal renal function and imaging?
Does co‑trimoxazole (trimethoprim‑sulfamethoxazole) cause worsening of renal function in a patient with chronic kidney disease and an estimated glomerular filtration rate of 12 mL/min?
How should tenofovir disoproxil fumarate (TDF)–induced elevation in serum creatinine be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.